IPOs such as this trade based on future sales and PE, not current. Take a look at Amazon, which still is not profitable (and forward PE is over 100). This company has a market cap that is 1/8 of DDD and 1/5 of SSYS. If it can grow to the size of those companies -- and based on the technology, that seems reasonable -- then there is still a lot of money to be made in this company. And there may -- or may not -- be the "retracement" that some folks are looking for. I have watched lots of companies shoot to the moon that I thought were overvalued, and I missed my opportunity to get in. If you want "value," buy value stocks, but don't expect explosive growth. We all want to get in at the bottom, but this is not possible. The goal is to make a profit.
I read message boards occasionally to get possible perspectives; unfortunately most of these posts are spam. I just do not see an investor/trader buying $200,000. of XONE stock, and posting it on a yahoo message board. This offers no insight and seems like a bogus pumping move. While I believe in the potential of XONE technology long term, I would much rather hear what makes you believe XONE is a good buy at this price, than how many shares you bought (whether it is true or bogus). Posts like yours make me want to short this stock, though I won't as it is not my investing style).
This is a 700 mil market cap, and as I understand it is 3-D printing in the commercial/industrial sector. If this goes to a 5B market cap (the size of DDD), it will be a 7x increase from here. This is the ground floor. You could end up in the basement or on the 50th floor, but the risk return looks pretty good. And they needed the cash from the secondary, so it was a smart and well timed move. Once investors realize that, the stock should recover.
Do you just make stuff up? The secondary already happened at $62. People who bought at that price are losing money, but there is no secondary at $42. THe secondary was closed and completed.
"In connection with the offering, the Company sold 1,106,000 shares, and the selling stockholders sold 1,948,400 shares (including the 398,400 shares sold on the exercise of the over-allotment option). ExOne received net proceeds of approximately $64.8 million from the offering after deducting underwriting discounts and commissions and estimated offering expenses."